Author:
Segal Neil H.,Gada Purvi,Senzer Neil,Gargano Michele A.,Patchen Myra L.,Saltz Leonard B.
Subject
Gastroenterology,Oncology
Reference23 articles.
1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012
2. Cetuximab plus FOLFIRI in the treatment of metastatic colorectal cancer (mCRC): the influence of KRAS and BRAF biomarkers on outcome: Updated data from the CRYSTAL trial;Cutsem;ASCO Gastrointestinal Cancers Symposium,2010
3. KRAS mutations preclude tumor shrinkage of colorectal cancers treated with cetuximab ASCO annual meeting (abstract 4132);De Roock;J Clin Oncol,2007
4. FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer;Bokemeyer;Eur J Cancer,2015
5. Immune recognition of fungal beta-glucans;Brown;Cell Microbiol,2005
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献